U.S. IVD And LDT For Autoimmune Diseases Market Size, Share & Trends Report

U.S. IVD And LDT For Autoimmune Diseases Market Size, Share & Trends Analysis Report By Type, By Technology (Immunoassays, Clinical Chemistry, Molecular Diagnostics), By Application (Psoriasis, Crohn’s Disease), And Segment Forecasts, 2025 - 2030

  • Report ID: GVR-1-68038-287-7
  • Number of Report Pages: 110
  • Format: PDF, Horizon Databook
  • Historical Range: 2018 - 2023
  • Forecast Period: 2025 - 2030 
  • Industry: Healthcare

Market Segmentation

  • U.S. IVD & LDT For Autoimmune Disease Type Outlook (Revenue, USD Million, 2018 - 2030)
    • IVD
      • IVD by Technology Outlook (Revenue, USD Million, 2018 - 2030)
        • Immunoassays
        • Clinical Chemistry
        • Hematology
        • Coagulation
        • Microbiology
        • Molecular Diagnostics
        • Others
      • IVD by Application Outlook (Revenue, USD Million, 2018 - 2030)
        • Addison’s Disease
        • Ankylosing Spondylitis
        • Alopecia Areata
        • Rheumatoid Arthritis
        • Systemic Lupus Erythematosus
        • Systemic Sclerosis
        • Psoriasis
        • Antiphospholipid Antibody Syndrome
        • Diabetes Type 1
        • Crohn’s Disease
        • Ulcerative Colitis
        • Narcolepsy
        • Multiple Sclerosis
        • Uveitis
        • Others
    • LDT
      • LDT by Technology Outlook (Revenue, USD Million, 2018 - 2030)
        • Immunoassays
        • Clinical Chemistry
        • Hematology
        • Coagulation
        • Microbiology
        • Molecular Diagnostics
        • Others
      • LDT by Application Outlook (Revenue, USD Million, 2018 - 2030)
        • Addison’s Disease
        • Ankylosing Spondylitis
        • Alopecia Areata
        • Rheumatoid Arthritis
        • Systemic Lupus Erythematosus
        • Systemic Sclerosis
        • Psoriasis
        • Antiphospholipid Antibody Syndrome
        • Diabetes Type 1
        • Crohn’s Disease
        • Ulcerative Colitis
        • Narcolepsy
        • Multiple Sclerosis
        • Uveitis
        • Others
  • U.S. IVD & LDT For Autoimmune Disease Technology Outlook (Revenue, USD Million, 2018 - 2030)
    • Immunoassays
    • Clinical Chemistry
    • Hematology
    • Coagulation
    • Microbiology
    • Molecular Diagnostics
    • Others
  • U.S. IVD & LDT For Autoimmune Disease Application Outlook (Revenue, USD Million, 2018 - 2030)
    • Addison’s Disease
    • Ankylosing Spondylitis
    • Alopecia Areata
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Psoriasis
    • Antiphospholipid Antibody Syndrome
    • Diabetes Type 1
    • Crohn’s Disease
    • Ulcerative Colitis
    • Narcolepsy
    • Multiple Sclerosis
    • Uveitis
    • Others

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2018 to 2030
  • Market estimates and forecast for product segments up to 2030
  • Country market size and forecast for product segments up to 2030
  • Market estimates and forecast for application segments up to 2030
  • Country market size and forecast for application segments up to 2030
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon